English
简体中文
Total: £ 56.28
Published Date: 2025-12-09 | Pages: 88 | Tables: 87 | Medical Care
The global market for Blood Test for Alzheimer's Disease was valued at US$ 53.55 million in the year 2024 and is projected to reach a revised size of US$ 116 million by 2031, growing at a CAGR of 13.6% during the forecast period.
Blood Test for Alzheimer's Disease is a diagnostic method that measures specific biomarkers in the blood to detect pathological changes associated with the condition, such as abnormal protein accumulation or neurodegeneration indicators. It provides a less invasive and more accessible alternative to traditional diagnostic tools by identifying biochemical signals linked to early or progressive stages of the disease. This approach supports earlier clinical intervention, broader screening potential, and more streamlined patient management within healthcare systems.
North American market for Blood Test for Alzheimer's Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Blood Test for Alzheimer's Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Blood Test for Alzheimer's Disease in Early Diagnosis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Blood Test for Alzheimer's Disease include Quanterix, C2N Diagnostics, Sysmex, Quest Diagnostics, Roche Diagnostics, Fujirebio, Labcorp, Cognitact, Amoneta Diagnostics, MagQu, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Blood Test for Alzheimer's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Test for Alzheimer's Disease.
The Blood Test for Alzheimer's Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Test for Alzheimer's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, by Analytical Technology and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Test for Alzheimer's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quanterix
C2N Diagnostics
Sysmex
Quest Diagnostics
Roche Diagnostics
Fujirebio
Labcorp
Cognitact
Amoneta Diagnostics
MagQu
Diadem
Vazyme
KingMed Diagnostics
DIAN Diagnostics
Anqun Bioengineering
Segment by Type
Amyloid Beta (Aβ)
Tau Proteins
Others
Segment by Analytical Technology
Immunoassay-based Tests
Mass Spectrometry-based Tests
Others
Segment by Application
Early Diagnosis
Clinical Research
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Analytical Technology etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Test for Alzheimer's Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Test for Alzheimer's Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Amyloid Beta (Aβ)
1.2.3 Tau Proteins
1.2.4 Others
1.3 Market by Analytical Technology
1.3.1 Global Blood Test for Alzheimer's Disease Market Size Growth Rate by Analytical Technology: 2020 VS 2024 VS 2031
1.3.2 Immunoassay-based Tests
1.3.3 Mass Spectrometry-based Tests
1.3.4 Others
1.4 Market by Application
1.4.1 Global Blood Test for Alzheimer's Disease Market Growth by Application: 2020 VS 2024 VS 2031
1.4.2 Early Diagnosis
1.4.3 Clinical Research
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Blood Test for Alzheimer's Disease Market Perspective (2020-2031)
2.2 Global Blood Test for Alzheimer's Disease Growth Trends by Region
2.2.1 Global Blood Test for Alzheimer's Disease Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Blood Test for Alzheimer's Disease Historic Market Size by Region (2020-2025)
2.2.3 Blood Test for Alzheimer's Disease Forecasted Market Size by Region (2026-2031)
2.3 Blood Test for Alzheimer's Disease Market Dynamics
2.3.1 Blood Test for Alzheimer's Disease Industry Trends
2.3.2 Blood Test for Alzheimer's Disease Market Drivers
2.3.3 Blood Test for Alzheimer's Disease Market Challenges
2.3.4 Blood Test for Alzheimer's Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Test for Alzheimer's Disease Players by Revenue
3.1.1 Global Top Blood Test for Alzheimer's Disease Players by Revenue (2020-2025)
3.1.2 Global Blood Test for Alzheimer's Disease Revenue Market Share by Players (2020-2025)
3.2 Global Top Blood Test for Alzheimer's Disease Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Blood Test for Alzheimer's Disease Revenue
3.4 Global Blood Test for Alzheimer's Disease Market Concentration Ratio
3.4.1 Global Blood Test for Alzheimer's Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Test for Alzheimer's Disease Revenue in 2024
3.5 Global Key Players of Blood Test for Alzheimer's Disease Head office and Area Served
3.6 Global Key Players of Blood Test for Alzheimer's Disease, Product and Application
3.7 Global Key Players of Blood Test for Alzheimer's Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Test for Alzheimer's Disease Breakdown Data by Type
4.1 Global Blood Test for Alzheimer's Disease Historic Market Size by Type (2020-2025)
4.2 Global Blood Test for Alzheimer's Disease Forecasted Market Size by Type (2026-2031)
5 Blood Test for Alzheimer's Disease Breakdown Data by Application
5.1 Global Blood Test for Alzheimer's Disease Historic Market Size by Application (2020-2025)
5.2 Global Blood Test for Alzheimer's Disease Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Blood Test for Alzheimer's Disease Market Size (2020-2031)
6.2 North America Blood Test for Alzheimer's Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Blood Test for Alzheimer's Disease Market Size by Country (2020-2025)
6.4 North America Blood Test for Alzheimer's Disease Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Test for Alzheimer's Disease Market Size (2020-2031)
7.2 Europe Blood Test for Alzheimer's Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Blood Test for Alzheimer's Disease Market Size by Country (2020-2025)
7.4 Europe Blood Test for Alzheimer's Disease Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Blood Test for Alzheimer's Disease Market Size (2020-2031)
8.2 Asia-Pacific Blood Test for Alzheimer's Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Blood Test for Alzheimer's Disease Market Size by Region (2020-2025)
8.4 Asia-Pacific Blood Test for Alzheimer's Disease Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Blood Test for Alzheimer's Disease Market Size (2020-2031)
9.2 Latin America Blood Test for Alzheimer's Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Blood Test for Alzheimer's Disease Market Size by Country (2020-2025)
9.4 Latin America Blood Test for Alzheimer's Disease Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Test for Alzheimer's Disease Market Size (2020-2031)
10.2 Middle East & Africa Blood Test for Alzheimer's Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Blood Test for Alzheimer's Disease Market Size by Country (2020-2025)
10.4 Middle East & Africa Blood Test for Alzheimer's Disease Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quanterix
11.1.1 Quanterix Company Details
11.1.2 Quanterix Business Overview
11.1.3 Quanterix Blood Test for Alzheimer's Disease Introduction
11.1.4 Quanterix Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.1.5 Quanterix Recent Development
11.2 C2N Diagnostics
11.2.1 C2N Diagnostics Company Details
11.2.2 C2N Diagnostics Business Overview
11.2.3 C2N Diagnostics Blood Test for Alzheimer's Disease Introduction
11.2.4 C2N Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.2.5 C2N Diagnostics Recent Development
11.3 Sysmex
11.3.1 Sysmex Company Details
11.3.2 Sysmex Business Overview
11.3.3 Sysmex Blood Test for Alzheimer's Disease Introduction
11.3.4 Sysmex Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.3.5 Sysmex Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Details
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Blood Test for Alzheimer's Disease Introduction
11.4.4 Quest Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.4.5 Quest Diagnostics Recent Development
11.5 Roche Diagnostics
11.5.1 Roche Diagnostics Company Details
11.5.2 Roche Diagnostics Business Overview
11.5.3 Roche Diagnostics Blood Test for Alzheimer's Disease Introduction
11.5.4 Roche Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.5.5 Roche Diagnostics Recent Development
11.6 Fujirebio
11.6.1 Fujirebio Company Details
11.6.2 Fujirebio Business Overview
11.6.3 Fujirebio Blood Test for Alzheimer's Disease Introduction
11.6.4 Fujirebio Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.6.5 Fujirebio Recent Development
11.7 Labcorp
11.7.1 Labcorp Company Details
11.7.2 Labcorp Business Overview
11.7.3 Labcorp Blood Test for Alzheimer's Disease Introduction
11.7.4 Labcorp Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.7.5 Labcorp Recent Development
11.8 Cognitact
11.8.1 Cognitact Company Details
11.8.2 Cognitact Business Overview
11.8.3 Cognitact Blood Test for Alzheimer's Disease Introduction
11.8.4 Cognitact Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.8.5 Cognitact Recent Development
11.9 Amoneta Diagnostics
11.9.1 Amoneta Diagnostics Company Details
11.9.2 Amoneta Diagnostics Business Overview
11.9.3 Amoneta Diagnostics Blood Test for Alzheimer's Disease Introduction
11.9.4 Amoneta Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.9.5 Amoneta Diagnostics Recent Development
11.10 MagQu
11.10.1 MagQu Company Details
11.10.2 MagQu Business Overview
11.10.3 MagQu Blood Test for Alzheimer's Disease Introduction
11.10.4 MagQu Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.10.5 MagQu Recent Development
11.11 Diadem
11.11.1 Diadem Company Details
11.11.2 Diadem Business Overview
11.11.3 Diadem Blood Test for Alzheimer's Disease Introduction
11.11.4 Diadem Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.11.5 Diadem Recent Development
11.12 Vazyme
11.12.1 Vazyme Company Details
11.12.2 Vazyme Business Overview
11.12.3 Vazyme Blood Test for Alzheimer's Disease Introduction
11.12.4 Vazyme Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.12.5 Vazyme Recent Development
11.13 KingMed Diagnostics
11.13.1 KingMed Diagnostics Company Details
11.13.2 KingMed Diagnostics Business Overview
11.13.3 KingMed Diagnostics Blood Test for Alzheimer's Disease Introduction
11.13.4 KingMed Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.13.5 KingMed Diagnostics Recent Development
11.14 DIAN Diagnostics
11.14.1 DIAN Diagnostics Company Details
11.14.2 DIAN Diagnostics Business Overview
11.14.3 DIAN Diagnostics Blood Test for Alzheimer's Disease Introduction
11.14.4 DIAN Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.14.5 DIAN Diagnostics Recent Development
11.15 Anqun Bioengineering
11.15.1 Anqun Bioengineering Company Details
11.15.2 Anqun Bioengineering Business Overview
11.15.3 Anqun Bioengineering Blood Test for Alzheimer's Disease Introduction
11.15.4 Anqun Bioengineering Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)
11.15.5 Anqun Bioengineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Blood Test for Alzheimer's Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Amyloid Beta (Aβ)
Table 3. Key Players of Tau Proteins
Table 4. Key Players of Others
Table 5. Global Blood Test for Alzheimer's Disease Market Size Growth Rate by Analytical Technology (US$ Million): 2020 VS 2024 VS 2031
Table 6. Key Players of Immunoassay-based Tests
Table 7. Key Players of Mass Spectrometry-based Tests
Table 8. Key Players of Others
Table 9. Global Blood Test for Alzheimer's Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Blood Test for Alzheimer's Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Blood Test for Alzheimer's Disease Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Blood Test for Alzheimer's Disease Market Share by Region (2020-2025)
Table 13. Global Blood Test for Alzheimer's Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Blood Test for Alzheimer's Disease Market Share by Region (2026-2031)
Table 15. Blood Test for Alzheimer's Disease Market Trends
Table 16. Blood Test for Alzheimer's Disease Market Drivers
Table 17. Blood Test for Alzheimer's Disease Market Challenges
Table 18. Blood Test for Alzheimer's Disease Market Restraints
Table 19. Global Blood Test for Alzheimer's Disease Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Blood Test for Alzheimer's Disease Market Share by Players (2020-2025)
Table 21. Global Top Blood Test for Alzheimer's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Test for Alzheimer's Disease as of 2024)
Table 22. Ranking of Global Top Blood Test for Alzheimer's Disease Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Blood Test for Alzheimer's Disease Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Blood Test for Alzheimer's Disease, Headquarters and Area Served
Table 25. Global Key Players of Blood Test for Alzheimer's Disease, Product and Application
Table 26. Global Key Players of Blood Test for Alzheimer's Disease, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Blood Test for Alzheimer's Disease Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Blood Test for Alzheimer's Disease Revenue Market Share by Type (2020-2025)
Table 30. Global Blood Test for Alzheimer's Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Blood Test for Alzheimer's Disease Revenue Market Share by Type (2026-2031)
Table 32. Global Blood Test for Alzheimer's Disease Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Blood Test for Alzheimer's Disease Revenue Market Share by Application (2020-2025)
Table 34. Global Blood Test for Alzheimer's Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Blood Test for Alzheimer's Disease Revenue Market Share by Application (2026-2031)
Table 36. North America Blood Test for Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Blood Test for Alzheimer's Disease Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Blood Test for Alzheimer's Disease Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Blood Test for Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Blood Test for Alzheimer's Disease Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Blood Test for Alzheimer's Disease Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Blood Test for Alzheimer's Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Blood Test for Alzheimer's Disease Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Blood Test for Alzheimer's Disease Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Blood Test for Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Blood Test for Alzheimer's Disease Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Blood Test for Alzheimer's Disease Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Blood Test for Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Blood Test for Alzheimer's Disease Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Blood Test for Alzheimer's Disease Market Size by Country (2026-2031) & (US$ Million)
Table 51. Quanterix Company Details
Table 52. Quanterix Business Overview
Table 53. Quanterix Blood Test for Alzheimer's Disease Product
Table 54. Quanterix Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 55. Quanterix Recent Development
Table 56. C2N Diagnostics Company Details
Table 57. C2N Diagnostics Business Overview
Table 58. C2N Diagnostics Blood Test for Alzheimer's Disease Product
Table 59. C2N Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 60. C2N Diagnostics Recent Development
Table 61. Sysmex Company Details
Table 62. Sysmex Business Overview
Table 63. Sysmex Blood Test for Alzheimer's Disease Product
Table 64. Sysmex Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 65. Sysmex Recent Development
Table 66. Quest Diagnostics Company Details
Table 67. Quest Diagnostics Business Overview
Table 68. Quest Diagnostics Blood Test for Alzheimer's Disease Product
Table 69. Quest Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 70. Quest Diagnostics Recent Development
Table 71. Roche Diagnostics Company Details
Table 72. Roche Diagnostics Business Overview
Table 73. Roche Diagnostics Blood Test for Alzheimer's Disease Product
Table 74. Roche Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 75. Roche Diagnostics Recent Development
Table 76. Fujirebio Company Details
Table 77. Fujirebio Business Overview
Table 78. Fujirebio Blood Test for Alzheimer's Disease Product
Table 79. Fujirebio Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 80. Fujirebio Recent Development
Table 81. Labcorp Company Details
Table 82. Labcorp Business Overview
Table 83. Labcorp Blood Test for Alzheimer's Disease Product
Table 84. Labcorp Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 85. Labcorp Recent Development
Table 86. Cognitact Company Details
Table 87. Cognitact Business Overview
Table 88. Cognitact Blood Test for Alzheimer's Disease Product
Table 89. Cognitact Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 90. Cognitact Recent Development
Table 91. Amoneta Diagnostics Company Details
Table 92. Amoneta Diagnostics Business Overview
Table 93. Amoneta Diagnostics Blood Test for Alzheimer's Disease Product
Table 94. Amoneta Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 95. Amoneta Diagnostics Recent Development
Table 96. MagQu Company Details
Table 97. MagQu Business Overview
Table 98. MagQu Blood Test for Alzheimer's Disease Product
Table 99. MagQu Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 100. MagQu Recent Development
Table 101. Diadem Company Details
Table 102. Diadem Business Overview
Table 103. Diadem Blood Test for Alzheimer's Disease Product
Table 104. Diadem Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 105. Diadem Recent Development
Table 106. Vazyme Company Details
Table 107. Vazyme Business Overview
Table 108. Vazyme Blood Test for Alzheimer's Disease Product
Table 109. Vazyme Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 110. Vazyme Recent Development
Table 111. KingMed Diagnostics Company Details
Table 112. KingMed Diagnostics Business Overview
Table 113. KingMed Diagnostics Blood Test for Alzheimer's Disease Product
Table 114. KingMed Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 115. KingMed Diagnostics Recent Development
Table 116. DIAN Diagnostics Company Details
Table 117. DIAN Diagnostics Business Overview
Table 118. DIAN Diagnostics Blood Test for Alzheimer's Disease Product
Table 119. DIAN Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 120. DIAN Diagnostics Recent Development
Table 121. Anqun Bioengineering Company Details
Table 122. Anqun Bioengineering Business Overview
Table 123. Anqun Bioengineering Blood Test for Alzheimer's Disease Product
Table 124. Anqun Bioengineering Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)
Table 125. Anqun Bioengineering Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Blood Test for Alzheimer's Disease Picture
Figure 2. Global Blood Test for Alzheimer's Disease Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Blood Test for Alzheimer's Disease Market Share by Type: 2024 VS 2031
Figure 4. Amyloid Beta (Aβ) Features
Figure 5. Tau Proteins Features
Figure 6. Others Features
Figure 7. Global Blood Test for Alzheimer's Disease Market Size Comparison by Analytical Technology (2020-2031) & (US$ Million)
Figure 8. Immunoassay-based Tests Features
Figure 9. Mass Spectrometry-based Tests Features
Figure 10. Others Features
Figure 11. Global Blood Test for Alzheimer's Disease Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Blood Test for Alzheimer's Disease Market Share by Application: 2024 VS 2031
Figure 13. Early Diagnosis Case Studies
Figure 14. Clinical Research Case Studies
Figure 15. Blood Test for Alzheimer's Disease Report Years Considered
Figure 16. Global Blood Test for Alzheimer's Disease Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Blood Test for Alzheimer's Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Blood Test for Alzheimer's Disease Market Share by Region: 2024 VS 2031
Figure 19. Global Blood Test for Alzheimer's Disease Market Share by Players in 2024
Figure 20. Global Blood Test for Alzheimer's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Blood Test for Alzheimer's Disease Revenue in 2024
Figure 22. North America Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Blood Test for Alzheimer's Disease Market Share by Country (2020-2031)
Figure 24. United States Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Blood Test for Alzheimer's Disease Market Share by Country (2020-2031)
Figure 28. Germany Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Ireland Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Blood Test for Alzheimer's Disease Market Share by Region (2020-2031)
Figure 36. China Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia & New Zealand Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Blood Test for Alzheimer's Disease Market Share by Country (2020-2031)
Figure 44. Mexico Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Blood Test for Alzheimer's Disease Market Share by Country (2020-2031)
Figure 48. Israel Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Quanterix Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 52. C2N Diagnostics Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 53. Sysmex Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 54. Quest Diagnostics Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 55. Roche Diagnostics Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 56. Fujirebio Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 57. Labcorp Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 58. Cognitact Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 59. Amoneta Diagnostics Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 60. MagQu Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 61. Diadem Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 62. Vazyme Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 63. KingMed Diagnostics Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 64. DIAN Diagnostics Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 65. Anqun Bioengineering Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
